Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 382 (2) , 111468
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874101)
- Shanghai Municipal Education Commission
- Science and Technology Commission of Shanghai Municipality (16ZR1420000)
- Health and Family Planning Commission of Sichuan Province (2017ZZ02016)
This publication has 20 references indexed in Scilit:
- MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targetsBMC Cancer, 2015
- Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial CarcinomaScientific Reports, 2015
- miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1Oncotarget, 2015
- MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cellsTumor Biology, 2014
- Carcinogenic mechanisms of endometrial cancer: Involvement of genetics and epigeneticsJournal of Obstetrics and Gynaecology Research, 2014
- Flotillin-2 is associated with breast cancer progression and poor survival outcomesJournal of Translational Medicine, 2013
- MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteinsCancer Letters, 2012
- Molecular Characteristics and Risk Factors in Endometrial CancerInternational Journal of Gynecological Cancer, 2010
- Correlation between NDRG1 and PTEN expression in endometrial carcinomaCancer Science, 2008
- Novel molecular profiles of endometrial cancer—new light through old windowsThe Journal of Steroid Biochemistry and Molecular Biology, 2008